Kinase gene haplotypes and gene-gene interactions in the Ras-Raf-MAPK signaling pathway: Association with antidepressant remission

International Clinical Psychopharmacology

Volumn 28, Issue 5, 2013, Pages 245-254

  Wang, Cong Jie ^a   Zhang, Zhi Jun ^b   Xu, Zhi ^b   Shi, Yan Yan ^c   Pu, Meng Jia ^b   Zheng, Zhi ^a   Wang, Xiu Zhen ^a   Zhang, Yu Mei ^d   Li, Ling Jiang ^e  

^a Huai'An No3 People's Hospital   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d Yangzhou Wutaishan Hospital   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

antidepressants; depression; efficacy; gene gene interaction; haplotype; signaling transduction

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; FLUOXETINE; GENOMIC DNA; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN UPTAKE INHIBITOR; RAF PROTEIN; RAS PROTEIN; SEROTONIN UPTAKE INHIBITOR;

ANTIDEPRESSANT ACTIVITY; ARTICLE; ASSOCIATION; CORRELATIONAL STUDY; DRUG EFFICACY; FEMALE; GENE CONSTRUCT; GENE INTERACTION; HAMILTON SCALE; HAPLOTYPE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; REMISSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EPISTASIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RAF KINASES; RAS PROTEINS; REMISSION INDUCTION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SEX CHARACTERISTICS;

EID: 84881554803     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328362c89f     Document Type: Article

References (42)

1. Adams JP, Sweatt JD (2002). Molecular psychology: Roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42:135-163
2. Ahokas A, Kaukoranta J, Wahlbeck K, Aito M (2001). Estrogen deficiency in severe postpartum depression: Successful treatment with sublingual physiologic 17beta-estradiol: A preliminary study. J Clin Psychiatry 62:332-336
3. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association
4. Bano S, Akhter S, Afridi MI (2004). Gender based response to fluoxetine hydrochloride medication in endogenous depression. J Coll Physicians Surg Pak 14:161-165
5. Bruning JC, Gillette JA, Zhao Y, Bjorbaeck C, Kotzka J, Knebel B, et al. (2000). Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Proc Natl Acad Sci USA 97:2462-2467
6. Chen AC, Shirayama Y, Shin K, Neve RL, Duman RS (2001). Expression of the cAMP response element binding protein(CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 49:753-762
7. Crisafulli C, Shim DS, Andrisano C, Pae CU, Chiesa A, Han C, et al. (2012). Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder. Psychiatry Res 198:39-46
8. Culpepper L (2011). Understanding the burden of depression. J Clin Psychiatry 72:e19
9. D'Sa C, Duman RS (2002). Antidepressants and neuroplasticity. Bipolar Disord 4:183-194
10. Dowlatshahi D, MacQueen GM, Wang JF, Young LT (1998). Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 352:1754-1755
11. Dudbridge F (2008). Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87-98
12. Duffy A, Grof P, Robertson C, Alda M (2000). The implication of genetics studies of major mood disorders for clinical practice. J Clin Psychiatry 61:630-637
13. Dwivedi Y, Mondal AC, Rizavi HS, Faludi G, Palkovits M, Sarosi A, et al. (2006). Differential and brain region-specific regulation of Rap-l and Epac in depressed suicide victims. Arch Gen Psychiatry 63:639-648
14. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, et al. (2003). The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23:7311-7316
15. Errico M, Crozier RA, Plummer MR, Cowen DS (2001). 5-HT(7) receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons. Neuroscience 102:361-367
16. First MB, Spitzer RL,Williams JB (1997). Structured clinical interview for DSM-IV Axis I disorders: SCID-I: Clinician version: Administration booklet. New York: American Psychiatric Press
17. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996). Transdermal estrogen for treatment of severe postnatal depression. Lancet 347:930-933
18. Hahn LW, Ritchie MD, Moore JH (2003). Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19:376-382
19. Hamilton JP, Siemer M, Gotlib IH (2008). Amygdala volume in major depressive disorder: A meta-Analysis of magnetic resonance imaging studies. Mol Psychiatry 13:993-1000
20. Horstmann S, Lucae S, Menke A, Hennings JM, Ising M, Roeske D, et al. (2010). Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment. Neuropsychopharmacology 35:727-740
21. Husain MM, Rush AJ, Wisniewski SR, McClintock SM, Fava M, Nierenberg AA, et al. (2009). Family history of depression and therapeutic outcome: Findings from STAR*D. J Clin Psychiatry 70:185-195
22. Keers R, Bonvicini C, Scassellati C, Uher R, Placentino A, Giovannini C (2011). Variation in GNB3 predicts response and adverse reactions to antidepressants. J Psychopharmacol 25:867-874
23. Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE (2006). Duloxetine efficacy for major depressive disorder in male vs. female patients: Data from 7 randomized, double-blind, placebo controlled trials. J Clin Psychiatry 67:761-770
24. Mamdani F, Alda M, Grof P, Young LT, Rouleau G, Turecki G (2008). Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet 147B:500-504
25. Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, A Gray N, et al. (2003). Enhancing neuronal plasticity and cellular resilience to develop novel improved therapeutics for difficult-To-Treat depression. Biol Psychiatry 53:707-742
26. McCauslin CS, Heath V, Colangelo AM, Malik R, Lee S, Mallei A, et al. (2006). CAAT/enhancer-binding protein delta and cAMP-response element-binding protein mediate inducible expression of the nerve growth factors gene in the central nervous system. J Biol Chem 281:17681-17688
27. Mervaala E, Föhr J, Könönen M, Valkonen-Korhonen M, Vainio P, Partanen K, et al. (2000). Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 30:117-125
28. Moncrieff J, Kirsch I (2005). Efficacy of antidepressants in adults. BMJ 331: 155-157
29. Morishita S, Kinoshita T (2008). Predictors of response to sertraline in patients with major depression. Hum Psychopharmacol 23:647-651
30. Narasimhan S, Lohoff FW (2012). Pharmacogenetics of antidepressant drugs: Current clinical practice and future directions. Pharmacogenomics 13:441-464
31. Nishimura T, Ishima T, Iyo M, Hashimoto K (2008). Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: Role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One 3:e2558
32. Porcelli S, Fabbri C, Drago A, Gibiino S, De Ronchi D, Serretti A (2011a). Genetics and antidepressants: Where we are. Clin Neuropsychiatry 8:99-150
33. Qi X, Lin W,Wang D, Pan Y,Wang W, Sun M (2009). A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav Brain Res 199:203-209
34. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. (2001). Multifact dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138-147
35. Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, et al. (2006). An evaluation of the quick inventory of depressive symptomatology and the Hamilton Rating Scale for Depression: A sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry 59:493-501
36. Shi YY, He L (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetics association at polymorphism loci. Cell Res 15:97-98
37. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S, et al. (2000). cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20:4030-4036
38. Wang L, Peng D, Xie B, Jiang K, Fang Y (2012). The extracellular signal-regulated kinase pathway may play an important role in mediating antidepressantstimulated hippocampus neurogenesis in depression. Med Hypotheses 79:87-91
39. Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen HU (1993). Sex differences in rates of depression: Cross-national perspectives. J Affect Disord 29:77-84
40. Weizman S, Gonda X, Dome P, Faludi G (2012). Pharmacogenetics of antidepressive drugs: A way towards personalized treatment of major depressive disorder. Neuropsychopharmacol Hung 14:87-101
41. Zill P, Baghai TC, Zwanzger P, Schule C, Minov C, Riedel M, et al. (2000). Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport 11:1893-1897
42. Zimmerman M, McGlinchey JB, Posternak MA, Friedman M, Boerescu D, Attiullah N (2008). Remission in depressed outpatients: More than just symptom resolution? J Psychiatr Res 42:797-801